Petmed Express (NASDAQ:PETS) will be releasing its earnings data before the market opens on Monday, July 22nd.
Petmed Express (NASDAQ:PETS) last posted its quarterly earnings data on Monday, May 6th. The company reported $0.32 EPS for the quarter, missing the Zacks’ consensus estimate of $0.46 by ($0.14). Petmed Express had a net margin of 13.32% and a return on equity of 28.96%. The company had revenue of $64.57 million for the quarter, compared to the consensus estimate of $69.06 million. During the same quarter last year, the company earned $0.50 earnings per share. The company’s revenue was down 4.1% compared to the same quarter last year.
NASDAQ PETS opened at $16.23 on Friday. Petmed Express has a 12 month low of $15.00 and a 12 month high of $41.45. The company has a market cap of $329.24 million, a P/E ratio of 8.85 and a beta of 0.52. The company’s fifty day moving average is $16.42.
Petmed Express Company Profile
PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.
See Also: Dividend Yield
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.